Radiographic Contrast Agent Nephropathy Clinical Trial
Official title:
RenalGuard System for Prevention of Contrast Induced Nephropathy - A Randomized Trial
The purpose of this study is to determine whether hydration with intravenous saline matched with urine output, using the device RenalGuard is superior to standard hydration with saline to prevent contrast-induced nephropathy.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00540904 -
Prevention of Contrast Induced Nephropathy in Oncology Patients With Sodium Bicarbonate
|
Phase 2 | |
| Recruiting |
NCT00584350 -
Prevention of Contrast Nephropathy During Diagnostic Coronary Angiogram or PCI With Hydratation Based on LEVDP
|
Phase 4 | |
| Recruiting |
NCT01820195 -
N-Acetyl Cystein and Contrast Nephropathy
|
Phase 3 | |
| Completed |
NCT02137863 -
Efficacy of Dexmedetomidine in Preventing Contrast Induced Nephropathy
|
Phase 4 | |
| Completed |
NCT01866800 -
The Effect of the Forced Diuresis With Matched Hydration in Reducing Acute Kidney Injury During TAVI
|
Phase 4 | |
| Active, not recruiting |
NCT01778140 -
Comparing Effects of Patient-specific Versus Non-patient-specific Computerized Reminder System
|
N/A | |
| Completed |
NCT02483143 -
NAC, NaHCO3 and NS Prophylaxis for CTPA in the ED on Suspicion of PE: A Randomized Controlled Trial
|
Phase 4 | |
| Completed |
NCT01525888 -
Renin-angiotensin-aldosterone System (RAAS) Blockade and Contrast Induced Nephropathy
|
N/A | |
| Recruiting |
NCT02643706 -
Relationship Between ALDH2 and CIN
|
N/A | |
| Terminated |
NCT01168024 -
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
|
Phase 3 | |
| Completed |
NCT02643602 -
Does Bicarbonate in Addition to Theophylline Reduce CIN?
|
N/A | |
| Terminated |
NCT01654328 -
Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy
|
N/A |